Non-Hodgkin's lymphomas with Burkitt-like cells are associated with c-Myc amplification and poor prognosis

References

• Horning S J, Rosenberg S A. The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N Engl J Med 1984; 311: 1471–1475
   PubMed Web of Science ®Google Scholar
• Acker B, Hoppe R T, Colby T V, Cox R S, Kaplan H S, Rosenberg S A. Histologic conversion in the non-Hodgkin's lymphomas. J Clin Oncol 1983; 1: 11–16
   PubMed Web of Science ®Google Scholar
• Matolcsy A. High-grade transformation of low-grade non-Hodgkin's lymphomas: mechanisms of tumor progression. Leuk Lymphoma 1999; 34: 215–259
   Google Scholar
• Murga Penas E M, Hinz K, Roser K, Copie-Bergman C, Wlodarska I, Marynen P, et al. Translocations t(11;18) (q21;q21) and t(14;18)(q32;q21) are the main chromosomal abnormalities involving MLT/MALT1 in MALT lymphomas. Leukemia 2003; 17: 2225–2229
   PubMed Web of Science ®Google Scholar
• Martinez-Climent J A, Alizadeh A A, Segraves R, Blesa D, Rubio-Moscardo F, Albertson D G, et al. Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and genes expression alterations. Blood 2003; 101: 3109–3117
   PubMed Web of Science ®Google Scholar
• Bea S, Ribas M, Hernandez J M, Bosch F, Pinyol M, Hernandez L, et al. Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood 1999; 93: 4365–4374
   PubMed Web of Science ®Google Scholar
• Baldini L, Fracchiolla N S, Cro L M, Trecca D, Romitti L, Polli E, et al. Frequent p53 gene involvement in splenic B-cell leukemia/lymphomas of possible marginal zone origin. Blood 1994; 84: 270–278
   PubMed Web of Science ®Google Scholar
• Lossos I S, Levy R. Higher-grade transformation of follicle center lymphoma is associated with somatic mutation of the 5′ noncoding regulatory region of the BCL-6 gene. Blood 2000; 96: 635–639
   PubMed Web of Science ®Google Scholar
• Lossos I S, Alizadeh A A, Diehn M, Warnke R, Thorstenson Y, Oefner P J, et al. Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes. Proc Natl Acad Sci USA 2002; 99: 8886–8891
   PubMed Web of Science ®Google Scholar
• Harris N L, Jaffe E S, Stein H, Banks P M, Chan J K, Cleary M L, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392
   PubMed Web of Science ®Google Scholar
• Macpherson N, Lesack D, Klasa R, Horsman D, Connors J M, Barnett M, Gascoyne R D. Small noncleaved, non-Burkitt's (Burkitt-like) lymphoma: Cytogenetic predict outcome and reflect clinical presentation. J Clin Oncol 1999; 5: 1558–1567
   Google Scholar
• , et al. The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's Lymphomas: summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112–2135
   PubMed Web of Science ®Google Scholar
• , et al. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997; 89: 3909–3918
   PubMed Web of Science ®Google Scholar
• Diebold J, Jaffe E S, Raphael M, Warnke R A. Burkitt's Lymphoma. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haemopoietic and Lympoid Tissues, E S Jaffe, N L Harris, H Stein, J W Vardiman. IARC Press, LyonFrance 2001; 181–184
   Google Scholar
• Nakamura N, Nakamine H, Tamaru J, Nakamura S, Yoshino T, Ohshima K, Abe M. The distinction between Burkitt Lymphoma and diffuse large B-Cell lymphoma with c-MYC rearrangement. Mod Pathol 2002; 15: 771–776
   PubMed Web of Science ®Google Scholar
• Fegan C D, White D, Sweeney M. C-myc amplification, double minutes and homogenous staining regions in a case of AML. Br J Haematol 1995; 90: 486–488
   PubMed Web of Science ®Google Scholar
• Braziel R M, Arber D A, Slovak M L, Gulley M L, Spier C, Kjeldsberg C, et al. The Burkitt-like lymphomas: a Southwest Oncology group study delineating phenotypic, genotypic, and clinical features. Blood 2001; 97: 3713–3720
   PubMed Web of Science ®Google Scholar
• Miller T P, Grogan T M, Dahlberg S, Spier C M, Braziel R M, Banks P M, et al. Prognostic significance of the Ki-67 associated proliferation antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group Trial. Blood 1994; 83: 1460–1466
   PubMed Web of Science ®Google Scholar
• Vitolo U, Gaidano G, Botto B, Volpe G, Audisio E, Bertini M, et al. Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: clinical relevance in 71 patients. Ann Oncol 1998; 9: 55–61
   PubMed Web of Science ®Google Scholar
• Kramer M H, Hermans J, Wijburg E, Philippo K, Geelen E, van Krieken J H, et al. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Blood 1998; 92: 3152–3162
   PubMed Web of Science ®Google Scholar
• Akasaka T, Akasaka H, Ueda C, Yonetani N, Maesako Y, Shimizu A, et al. Molecular and clinical features of non-Burkitt's, diffuse large-cell lymphoma of B-cell type associated with the c-myc/immunoglobulin heavy-chain fusion gene. J Clin Oncol 2000; 18: 510–518
   PubMed Web of Science ®Google Scholar
• Akasaka T, Muramatsu M, Ohno H, Miura I, Tatsumi E, Fukuhara S, et al. Application of long-distance polymerase chain reaction to detection of junctional sequences created by chromosomal translocation in mature B-cell neoplasms. Blood 1996; 88: 985–994
   PubMed Web of Science ®Google Scholar
• Prk C -K, Lee C -G, Lee J -D. Detection of MYC gene amplification in malignant lymphomas. J Korean Med Sci 1998; 13: 159–164
   PubMedGoogle Scholar
• Xu W S, Liang R H, Srivastava G. Identification and characterization of BCL6 translocation partner genes in primary gastric high-grade B-cell lymphoma: heat shock protein 89 alpha is a novel fusion partner gene of BCL6. Genes Chromosomes Cancer 2000; 27: 69–75
   PubMed Web of Science ®Google Scholar
• Hernandez L, Hernandez S, Bea S, Pinyol M, Ferrer A, Bosch F, et al. c-myc mRNA expression and genomic alterations in mantle cell lymphomas and other nodal non-Hodgkin's lymphomas. Leukemia 1999; 13: 2087–2093
   PubMed Web of Science ®Google Scholar
• Ohno H, Fukuhara S, Arita Y, Doi S, Takahashi R, Fujii H, et al. Establishment of a peripheral T-cell lymphoma cell line showing amplification of the c-myc oncogene. Cancer Res 1988; 48: 4959–4963
   PubMed Web of Science ®Google Scholar